Qube Research & Technologies LTD Harrow Health, Inc. Transaction History

Qube Research & Technologies LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$8.1 - $16.36 $445,581 - $899,963	55,010 New	55,010 $616,000
Q1 2023 May 15, 2023	BUY	$13.84 - $21.46 $1.03 Million - $1.6 Million	74,376 Added 314.07%	98,057 $2.07 Million
Q4 2022 Feb 14, 2023	BUY	$10.28 - $14.78 $87,174 - $125,334	8,480 Added 55.79%	23,681 $349,000
Q3 2022 Nov 14, 2022	BUY	$6.57 - $24.88 $3,639 - $13,783	554 Added 3.78%	15,201 $183,000
Q2 2022 Aug 15, 2022	BUY	$5.75 - $7.74 $84,220 - $113,367	14,647 New	14,647 $107,000
Q2 2020 Aug 14, 2020	SELL	$3.61 - $6.47 $222,960 - $399,600	-61,762 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$3.5 - $7.31 $141,883 - $296,332	-40,538 Reduced 39.63%	61,762 $236,000
Q4 2019 Feb 13, 2020	BUY	$4.6 - $7.88 $470,579 - $806,124	102,300 New	102,300 $796,000

179

21.3M

845K

717K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $885M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.